吉林大学学报(医学版) ›› 2020, Vol. 46 ›› Issue (03): 607-613.doi: 10.13481/j.1671-587x.20200328

• 临床研究 • 上一篇    

慢性HBV感染者外周血单个核细胞中miR-194-5p和MagT1表达水平检测及其意义

林晓娥1, 吴景华2, 黎洁1, 刘洋3, 谌晓楠3, 祝朝前3, 李广平1   

  1. 1. 河北省唐山市工人医院检验科, 河北 唐山 063000;
    2. 华北理工大学附属医院检验科, 河北 唐山 063000;
    3. 河北省唐山市工人医院肝胆外科, 河北 唐山 063000
  • 收稿日期:2019-07-12 发布日期:2020-06-11
  • 通讯作者: 林晓娥,副主任技师(Tel:0315-3722303,E-mail:xiaoe721@163.com) E-mail:xiaoe721@163.com
  • 作者简介:林晓娥(1975-),女,河北省唐山市人,副主任技师,医学硕士,主要从事检验医学方面的研究。
  • 基金资助:
    河北省自然科学基金资助课题(H2016209007);河北省唐山市科技局科技支撑计划项目资助课题(12130296b)

Detection of expression levels of miR-194-5p and MagT1 in peripheral blood mononuclear cells of patients with chronic HBV infection and their significances

LIN Xiaoe1, WU Jinghua2, LI Jie1, LIU Yang3, SHEN Xiaonan3, ZHU Chaoqian3, LI Guangping1   

  1. 1. Department of Clinical Laboratory, Tangshan Worker's Hospital, Tangshan 063000, China;
    2. Department of Clinical Laboratory, Affiliated Hospital, North China University of Science and Technology, Tangshan 063000, China;
    3. Department of Hepatobiliary Surgery, Tangshan Worker's Hospital, Tangshan 063000, China
  • Received:2019-07-12 Published:2020-06-11

摘要: 目的:检测慢性乙型肝炎病毒(HBV)感染者外周血单个核细胞(PBMCs)中miR-194-5p和镁离子(Mg2+)转运蛋白1(MagT1)表达水平,阐明其可能的临床意义。方法:收集40例健康体检者(健康对照组)、40例HBV携带者(HBV携带组)、40例轻中度慢性乙型肝炎(轻中度CHB组)和40例重度慢性乙型肝炎(重度CHB组)患者的临床资料。采集各组研究对象外周血并利用Ficoll-Hypaque密度梯度离心法分离PBMCs,采用RT-PCR法检测各组研究对象PBMCs中miR-194-5p及MagT1 mRNA表达水平,Western blotting法检测各组研究对象PBMCs中MagT1蛋白表达水平,检测各组研究对象外周血和PBMCs中Mg+水平,流式细胞术检测各组研究对象PBMCs中CD8+T淋巴细胞表面分子程序性死亡受体1(PD-1)和自然杀伤细胞受体2群D分子(NKG2D)表达水平。在293T细胞中分别转染miR-194-5p mimic质粒(miR-194-5p mimic组)和miR-NC质粒(miR-NC组),应用双荧光素酶报告基因实验检测2组293T细胞中荧光素酶活性。结果:与健康对照组比较,HBV携带组、轻中度CHB组和重度CHB组患者PBMCs中MagT1 mRNA和蛋白表达水平、Mg2+水平及CD8+T淋巴细胞表面分子NKG2D表达水平均明显降低(P<0.05),miR-194-5p mRNA及CD8+T淋巴细胞表面分子PD-1表达水平升高(P<0.05)。与HBV携带组和轻中度CHB组比较,重度CHB组患者PBMCs中MagT1 mRNA和蛋白表达水平、Mg2+水平及CD8+T淋巴细胞表面分子NKG2D表达水平均降低(P<0.05),miR-194-5p mRNA及CD8+T细胞表面分子PD-1表达水平降低(P<0.05)。与HBV携带组比较,轻中度CHB组患者PBMCs中MagT1 mRNA和蛋白表达水平、Mg2+水平及CD8+T淋巴细胞表面分子NKG2D表达水平降低(P<0.05),miR-194-5p mRNA及CD8+T淋巴细胞表面分子PD-1表达水平升高(P<0.05)。双荧光素酶报告基因实验,MagT1是miR-194-5p靶基因。结论:miR-194-5p可能通过靶向下调MagT1表达,引起MagT1介导的Mg2+内流障碍,造成CD8+T淋巴细胞免疫活性降低,导致乙型肝炎慢性发展。

关键词: 乙型肝炎病毒, 外周血单个核细胞, miR-194-5p, 镁离子转运蛋白1

Abstract: Objective: To detect the expression levels of miR-194-5p and magnesium transporter protein1(MagT1) in peripheral blood mononuclear cells (PBMCs) of the patients with chronic hepatitis B virus(HBV) infection, and to investigate their possible clinical significances. Methods: The clinical materials of 40 healthy subjects (healthy control group), 40 cases of asymptomatic hepatitis B carriers(HBV carrier group), 40 patients with mild-moderate chronic hepatitis B (mild-moderate CHB group) and 40 patients with severe chronic hepatitis B (severe CHB group) were collected. The peripheral blood of the subjects in various groups was collected and the PBMCs were isolated by Ficoll-Hypaque density gradient centrifugation. The expression levels of miR-194-5p and MagT1 mRNA in PBMCs of the subjects in various groups were detected by RT-PCR assay, the expression levels of MagT1 protein in PBMCs of the subjects in various groups were detected by Western blotting method,the levels of Mg2+ in peripheral blood and PBMCs of the subjects in various groups were detected, and the expression levels of CD8+ T lymphocyte surface molecules programmed death receptor 1(PD-1) and natural killer cell receptor 2 group D molecule (NKG2D) in PBMCs of the subjects in various groups were analyzed by flow cytometry. The miR-194-5p mimic (miR-194-5p mimic group)and miR-NC(miR-NC group) were transfected into the 293T cells, and then the dual luciferase reporter gene assay was used to detect the luciferase activities in 293T cells in two groups. Results: Compared with healthy control group, the expression levels of MagT1 mRNA and protein, the expression levels of CD8+ T lymphocyte surface molecule NKG2D and the levels of Mg2+ in PBMCs of the patients in HBV carrier group, mild-moderate CHB group and severe CHB group were decreased(P<0.05),the expression levels of miR-194-5p mRNA in PBMCs and CD8+ T lymphocyte surface molecule PD-1 of the patients were increased(P<0.05).Compared with HBV carrier group and mild-moderate CHB group,the expression levels of MagT1 mRNA and protein, the expression level of CD8+ T lymphocyte surface molecule NKG2D and the level of Mg2+ in PBMCs of the patients in severe CHB group were decreased (P<0.05), and the expression levels of miR-194-5p mRNA in PBMCs and CD8+ T lymphocyte surface molecule PD-1 of the patients were increased (P<0.05).Compared with HBV carrier group, the expression levels of MagT1 mRNA and protein, the expression level of CD8+ T lymphocyte surface molecule NKG2D and the level of Mg2+ in PBMCs of the patients in mild-moderate CHB group were decreased(P<0.05),and the expression levels of miR-194-5p mRNA in PBMCs and CD8+ T lymphocyte surface molecule PD-1 of the patients were increased (P<0.05).The dual luciferase reporter gene assay results confirmed that MagT1 was a miR-194-5p target gene. Conclusion: MiR-194-5p may lead to chronic development of hepatitis B by down-regulating the expression of MagT1, causing MagT1-mediated Mg2+ influx disorder and resulting in the decrease of the immune activity of CD8+ T lymphocyte.

Key words: hepatitis B virus, peripheral blood mononuclear cell, miR-194-5p, magnesium transporter protein 1

中图分类号: 

  • R512.62